Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MAOA-IN-1 (compound 15) is an orally-active inhibitor of monoamine oxidase A (MAOA) that exhibits cytotoxic effects on prostate cancer cells. This compound demonstrates Caco-2 permeability while maintaining reduced central nervous system (CNS) permeability, indicating its potential utility in anti-cancer and anti-inflammatory research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | MAOA-IN-1 (compound 15) is an orally-active inhibitor of monoamine oxidase A (MAOA) that exhibits cytotoxic effects on prostate cancer cells. This compound demonstrates Caco-2 permeability while maintaining reduced central nervous system (CNS) permeability, indicating its potential utility in anti-cancer and anti-inflammatory research [1]. |
Molecular Weight | 303.18 |
Formula | C13H16Cl2N2O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MAOA-IN-1 Neuroscience Monoamine Oxidase inhibitor inhibit